REGISTER NOW
SUBMIT ABSTRACT
7th World Cancer Congress - 2022 | Bangalore 2nd Global Surgery Summit - 2022 | Bangkok | Thailand 7th World Cancer Congress - 2022 | Bangalore
Early Bird Registration Closes: 11th June, 2022, 1st Phase Abstract Submission Closes: 11th September, 2022

MARKET ANALYSIS

The Indian pharmaceutical industry is the world’s 3rd largest by volume and 14th largest in terms of value. Total Annual Turnover of Pharmaceuticals was Rs. 2,89,998 crore for the year 2019-2020. Total pharmaceutical exports and import were to the tune of Rs. 1,46,260 crore and Rs. 42,943 crore respectively in the year 2019-20.

Major Segments of Pharmaceutical Industry are Generic drugs, OTC Medicines and API/Bulk Drugs, Vaccines, Contract Research & Manufacturing, Biosimilars & Biologics. India has the second-highest number of US FDA approved plants outside the US. India is a global leader in the supply of DPT, BCG, and Measles vaccines. India accounts for 60 percent of global vaccine production, contributing 40 to 70 percent of the WHO demand for Diphtheria, Tetanus and Pertussis (DPT) and Bacillus Calmette–Guérin (BCG) vaccines, and 90 percent of the WHO demand for the measles vaccine.

India is the largest provider of generic drugs globally. Access to affordable HIV treatment from India is one of the greatest success stories in medicine. India is one of the biggest suppliers of low-cost vaccines in the world. Because of the low price and high quality, Indian medicines are preferred worldwide, thereby rightly making the country the “Pharmacy of the World”. Pharma sector currently contributes to around 1.72% of the country’s GDP.

India’s pharmaceutical sector forms a major component of the country’s foreign trade, with attractive avenues and opportunities for investors. India supplies affordable and low-cost generic drugs to millions of people across the globe and operates a significant number of United States Food and Drug Administration (USFDA) and World Health Organization (WHO) Good Manufacturing Practices (GMP)-compliant plants. India has occupied a premier position among pharmaceutical manufacturing countries of the world.

India is 3rd largest market for APIs globally, 8% share in Global API Industry, 500+ different APIs are manufactured in India and it contributes 57% of APIs to prequalified list of the WHO.

Medical device industry in India has the potential to reach $50 bn by 2025. India is the 4th largest Asian medical devices market after Japan, China, and South Korea and also ranks among the top 20 global medical device markets in the world

Pharmaceutical is one of the top ten attractive sectors for foreign investment In India. 100% foreign investment is allowed under automatic route in Medical Devices. Foreign investments in pharmaceutical greenfield projects are allowed upto 100% under the automatic route and for brownfield pharmaceutical projects, foreign investment beyond 74% to upto 100% Government approval is required.




7th World Congress on Drug Discovery and Development - 2022 | Bangalore

CONTACT US AT

Conference Secretariat
UNITED STATES
ARJYOPA HEALTHCARE
16192 Coastal Hwy., Lewes, DE 19958, US


INDIA
ARJYOPA HEALTHCARE
#2 RBC Road, Dumdum
Kolkata - 700028, West Bengal, India

WRITE TO US


7th World Cancer Congress - 2022 | Bangalore




SUBMIT ABSTRACT | ONLINE REGISTRATION | CONTACT US | WHO SHOULD ATTEND | WHY ATTEND | FOCUS OF THE CONFERENCE | MARKET ANALYSIS | SPONSOR | KEY TRACKS | CONFERENCE AGENDA | VENUE | ALEXANDER FLEMING AWARD | ASIMA CHATTERJEE AWARD | YOUNG RESEARCHER AWARD
_______________________________________________________________________________________________________________________

MAIL US AT
Sponsorship/Exhibitions: [email protected]
General Enquiries: [email protected]

______________________________________________________________________________________

[email protected], Arjyopa Healthcare. All Right Reserved